The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 262.00
Bid: 262.60
Ask: 263.00
Change: 0.20 (0.08%)
Spread: 0.40 (0.152%)
Open: 262.20
High: 264.00
Low: 261.20
Prev. Close: 261.80
CTEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convatec Group PLC: Scrip Dividend - Calculation Price

17 Apr 2023 16:55

Convatec Group PLC (CTEC) Convatec Group PLC: Scrip Dividend - Calculation Price 17-Apr-2023 / 16:55 GMT/BST


Scrip Dividend – calculation price

 

Reading, United Kingdom (17 April 2023)

On 8 March 2023, the Board of Directors of Convatec Group Plc (“Convatec” or “the Company”) proposed a final dividend of 4.330 cents per share (“Final Dividend”), subject to approval at the forthcoming Annual General Meeting on 18 May 2023. This Final Dividend is to be paid on 25 May 2023 to shareholders on the share register as of 11 April 2023 (“Record Date”). The Final Dividend is payable in cash, in sterling to holders of ordinary shares. The chosen exchange rate for this payment is $1.184/£1.00, determined on 8 March 2023, giving a total sterling dividend of £74,744,400.80 A scrip dividend will be made available for this Final Dividend, allowing shareholders to elect to receive their dividend in the form of new ordinary shares.

The “Calculation Price” for the issue of new ordinary shares under the scrip dividend scheme is:

221.2 pence for each new ordinary share.

This is equivalent to 1 new share for approximately 60.49 shares held prior to the ex-dividend date of 6 April 2023.

The Calculation Price is the average of the middle market quotations of a Convatec share, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 6 April to 14 April 2023 (inclusive).

The latest date for receipt of elections to participate in the scrip dividend scheme for the Final Dividend is 3 May 2023. Shareholders must return their mandate form by 5pm (BST) or otherwise input their CREST elections to be received by the Company’s registrar, Computershare, by 3pm (BST). Elections received after this deadline will apply to subsequent dividends only. Unless revoked by a shareholder, a scrip dividend election will apply for all future dividends for which a scrip dividend is offered. Evergreen elections for CREST shareholders cannot be accepted and elections will revert to cash by default after the payment of each dividend.

Details of the scrip dividend scheme are available at www.convatecgroup.com/investors.

TIMETABLE

Key dates in respect of the scrip dividend scheme for the Final Dividend are:

Ex-dividend Date           6 April 2023

Record Date          11 April 2023

Scrip calculation price determined    6 April - 14 April 2023 (inclusive)

Scrip calculation price available and announced      17 April 2023

Mandate delivery deadline for Shares held in uncertificated form    3.00 p.m. on 3 May 2023

Mandate delivery deadline for Shares held in certificated form    5.00 p.m. on 3 May 2023 

Announcement of the total amount of new shares to be issued     9 May 2023

Dividend payment date         25 May 2023

Dispatch of statement in accordance with section 7 of Scheme     25 May 2023

Rules and share certificates, CREST accounts credited/updated

Enquiries 

 

Louise Bryson, Assistant Company Secretary   +44(0)7423 694919

 

Cosec@convatec.com 

 

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

 

About Convatec  

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products

and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:GB00BD3VFW73
Category Code:DIV
TIDM:CTEC
LEI Code:213800LS272L4FIDOH92
Sequence No.:237436
EQS News ID:1609573
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
13th Sep 202212:08 pmEQSConvatec Group PLC: Scrip Dividend – Calculation Price
16th Aug 202212:00 pmEQSConvatec Group PLC: Director/PDMR Shareholding
16th Aug 202212:00 pmEQSConvatec Group PLC: Director/PDMR Shareholding
4th Aug 20227:00 amRNSInterim Results
7th Jul 202211:53 amRNSDirector Declaration
28th Jun 20225:26 pmRNSBlock listing Interim Review
31st May 20222:00 pmRNSTotal Voting Rights
19th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20224:25 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Trading Update
4th May 20223:31 pmRNSScrip Dividend - Total Issued Shares
3rd May 20227:00 amRNSNotice of Forthcoming Scheduled IR Events
7th Apr 20223:45 pmRNSScrip Dividend – Calculation Price
1st Apr 20224:00 pmRNSHolding(s) in Company
31st Mar 20223:45 pmRNSTotal Voting Rights
30th Mar 202212:00 pmRNSAnnual Report and Accounts 2021 and Notice of AGM
25th Mar 20222:00 pmRNSDirector/PDMR Shareholding
23rd Mar 202211:30 amRNSDirector/PDMR Shareholding
17th Mar 20222:40 pmRNSDirector/PDMR Shareholding
17th Mar 20222:20 pmRNSBoard Change
14th Mar 20227:00 amRNSAcquisition Completion of Triad Life Sciences Inc
8th Mar 20227:00 amRNSAnnual Results
28th Feb 202211:00 amRNSNon-Executive Director Changes
10th Feb 20223:15 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSAcquisition: entry into attractive wound biologics
27th Jan 202211:00 amRNSBoard Committee Changes
20th Dec 20218:45 amRNSBlock Listing Application
16th Dec 20212:00 pmRNSNon-Executive Director appointment
9th Dec 20217:00 amRNSChief Financial Officer succession
1st Nov 20213:35 pmRNSTotal Voting Rights
29th Oct 20217:00 amRNSQ3 Trading Update
18th Oct 20214:30 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSPricing of $500M 3.875% Senior Notes due 2029
30th Sep 20211:13 pmRNSConvaTec Announces Offer of $500M Senior Notes
28th Sep 20213:15 pmRNSScrip Dividend - Total Issued Shares
9th Sep 20213:00 pmRNSScrip Dividend - Calculation Price
30th Jul 20213:45 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSInterim Results
28th Jun 202112:40 pmRNSDirector Declaration
1st Jun 202111:45 amRNSTotal Voting Rights
17th May 20213:15 pmRNSDirector/PDMR Shareholding
7th May 20212:50 pmRNSResult of AGM
29th Apr 20217:00 amRNSQ1 Trading Update
28th Apr 202112:45 pmRNSScrip Dividend - Total Issued Shares
12th Apr 20213:15 pmRNSScrip Dividend - Calculation Price
22nd Mar 20213:40 pmRNSAnnual Report and Accounts 2020 and Notice of AGM
11th Mar 20213:50 pmRNSDirector/PDMR Shareholding
5th Mar 20217:00 amRNSAnnual Results
22nd Feb 202111:30 amRNSDirector Declaration
21st Dec 202011:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.